| PERIOD ENDING | 5-Jul-08 | 5-Apr-08 | 29-Dec-07 | 29-Sep-07 | | Total Revenue | 966,761 | 1,121,542 | 1,122,194 | 1,171,376 | | Cost of Revenue | 508,210 | 590,615 | 621,034 | 583,174 | | | Gross Profit | 458,551 | 530,927 | 501,160 | 588,202 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 481,673 | 554,904 | 582,861 | 514,894 | | Non Recurring |
-
|
-
| 474,819 | 12,300 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (23,122) | (23,977) | (556,520) | 61,008 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (924) | (2,748) | (2,585) | (1,480) | | Earnings Before Interest And Taxes | (24,046) | (26,725) | (559,105) | 59,528 | | Interest Expense | 9,770 | 12,103 | 12,062 | 11,778 | | Income Before Tax | (33,816) | (38,828) | (571,167) | 47,750 | | Income Tax Expense | (19,076) | (23,984) | (143,743) | 20,175 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (14,740) | (14,844) | (427,424) | 27,575 | | | Non-recurring Events | | Discontinued Operations | (8,423) | (16,177) | (8,254) | 5,476 | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (23,163) | (31,021) | (435,678) | 33,051 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($23,163) | ($31,021) | ($435,678) | $33,051 |
|
2.99% Nasdaq 
Income Statement
